Aehr Test Systems reported significant changes in its financial performance for the first fiscal quarter of 2025, which ended on August 30, 2024. The company achieved net revenues of $555.97 million, a substantial increase from $50.49 million in the same period of the previous year. This growth was primarily driven by a notable increase in sales, particularly in the United States, which accounted for $523.79 million of total revenues. However, revenues from Asia and Europe saw declines, with Asia dropping to $12.58 million from $19.23 million in 2023.

Despite the revenue surge, net income for the quarter was $660,000, a significant decrease from $4.67 million reported in the prior year. The decline in profitability was attributed to increased selling, general, and administrative expenses, which rose to $4.6 million from $3.4 million, largely due to acquisition-related costs and expenses from the newly acquired Incal Technology, Inc. Additionally, research and development expenses remained relatively stable at $2.4 million, compared to $2.5 million in the previous year.

The company completed the acquisition of Incal Technology on July 31, 2024, for a total consideration of $21.9 million, which included cash and restricted stock. The acquisition is expected to enhance Aehr's product offerings and market position, although the revenue contribution from Incal was minimal at $200,000 for the quarter.

Gross profit for the quarter was reported at $7.1 million, down from $10 million in the same period last year, but the gross margin improved to 54.0% from 48.4%. This increase in gross margin was attributed to a shift towards higher-margin contactor sales, despite lower manufacturing efficiencies due to reduced system shipments.

Cash, cash equivalents, and restricted cash totaled $40.8 million as of August 30, 2024, down from $51.1 million a year earlier. The decrease in cash flows from operating activities to $2.38 million, down from $3.90 million, was linked to lower net income and reduced cash from deferred revenue and accounts receivable collections.

Overall, Aehr Test Systems is navigating a complex market environment, with strategic acquisitions and shifts in product demand impacting its financial results. The company continues to focus on enhancing its operational capacity and addressing market trends in semiconductor testing.

About AEHR TEST SYSTEMS

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.